GlassScriptPhysician profile
David H Park
NPI 1326057969
$7,887.38
in general payments reported to CMS, 2019-2025
27 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,568 · 2020: $488 · 2021: $1,502 · 2022: $777 · 2023: $1,288 · 2024: $1,380 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,536 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,536.06 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,933.24 | 2019-2023 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $1,290.38 | 2019-2025 | Oasis, Stravix Pl, Grafix |
| Davol INC. | $1,156.88 | 2019-2025 | Phasix Mesh |
| Kerecis Limited | $1,127.49 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| W. L. Gore & Associates, INC. | $586.77 | 2019-2022 | |
| Organogenesis INC. | $566.72 | 2019-2022 | |
| Baxter Healthcare | $413.84 | 2023-2025 | Perclot, Tisseel |
| Conmed Corporation | $136.38 | 2019-2023 | Airseal |
| Urgo Medical North America, LLC | $114.33 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Osiris Therapeutics INC. | $80.04 | 2019 | |
| Shire North American Group INC | $72.38 | 2019 | |
| Angiodynamics, INC. | $41.52 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.50 | 2020-2021 | |
| Polynovo North America LLC | $34.20 | 2024 | Novosorb Btm |
| Ets Wound Care LLC | $34.00 | 2025 | Mirragen Advanced Wound Matrix |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $33.06 | 2024 | V.A.C. Veraflo Cleanse Choice |
| Kowa Pharmaceuticals America, INC. | $28.54 | 2022 | |
| Lifenet Health | $26.68 | 2024 | Theragenesis Wound Matrix |
| Kci USA, INC. | $25.82 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Merck Sharp & Dohme LLC | $24.01 | 2019 | |
| Stryker Corporation | $21.33 | 2021 | |
| Melinta Therapeutics, LLC | $21.29 | 2019 | |
| Myriad Genetic Laboratories, INC. | $19.94 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.33 | 2022 | |
| Amarin Pharma, INC. | $17.08 | 2019 | |
| Integra Lifesciences Corporation | $15.06 | 2019 | |
| Allergan, INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.